LakeShore Biopharma Co., Ltd.
Pharmaceutical Preparations · DAXING DISTRICT, BEIJING
High confidence (85%)
Updated Oct 13, 2026, 12:04 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
Latest material event: LakeShore Biopharma Co., Ltd. deregistered its securities (Jun 24, 2026)
Timeline
Every material event, newest first. History is never overwritten.
LakeShore Biopharma Co., Ltd. deregistered its securities
Jun 24, 2026
Registration withdrawn
- SEC EDGAR — “15-12G 1 ea0295620-1512g_lakeshore.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-41598 LAKESHORE BIOPHARMA CO., LTD (Exact name of registrant as specified in its charter) Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, PRC 102600 010-89202086 (Address, includ…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker LSBCF.
- SEC CIK
- 0001946399
- Website
- —
- —
- Headquarters
- DAXING DISTRICT, BEIJING
- Also known as
- YishengBio Co., Ltd, YS Biopharma Co., Ltd.
- Legal entities
- LakeShore Biopharma Co., Ltd.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
LakeShore Biopharma Co., Ltd. — Pharmaceutical Preparations (SIC 2834) — DAXING DISTRICT, BEIJING, China
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
15-12G 1 ea0295620-1512g_lakeshore.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-41598 LAKESHORE BIOPHARMA CO., LTD (Exact name of registrant as specified in its charter) Building No. 2, 38 Yongda Road, Daxing Biomedical Industry Park, Daxing District, Beijing, PRC 102600 010-89202086 (Address, includ…
View source record
Status history
Every derived status, with the rule that produced it.
- NO_LONGER_LISTED → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:28 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 18, 2026, 01:12 AM
The company deregistered its securities and stopped filing with the SEC. Companies do that when they are acquired, when they go private, and when they fail; the filing does not say which.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:16 AM
The company stopped being publicly listed. That happens to failing companies and to acquired ones alike.